Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GSDIa Disease Monitoring Program

NCT06636383 is registered in ClinicalTrials.gov with Ultragenyx Pharmaceutical Inc as lead sponsor.

NCT NCT06636383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06636383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GSDIa Disease Monitoring Program
Lead sponsor
Ultragenyx Pharmaceutical Inc
Phase
Observational
Overall status
Recruiting
Start date
November 4, 2024
Completion date
December 31, 2036
Enrollment
140 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

glycogen storage disease type ia